Spots Global Cancer Trial Database for cns lymphoma
Every month we try and update this database with for cns lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor | NCT03536039 | Lymphoma, Large... | NGR-hTNF RITUXIMAB Doxorubicin Cyclophosphamid... Vincristine Prednisone | 18 Years - 80 Years | IRCCS San Raffaele | |
| CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study | NCT05828628 | CNS Lymphoma | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma | NCT05351593 | CNS Lymphoma Primary Central... Secondary Centr... | Tafasitamab Lenalidomide | 18 Years - | University of California, San Francisco | |
| Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma | NCT00267865 | AIDS-Related-Pr... | Methotrexate Rituximab Leucovorin | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor | NCT03536039 | Lymphoma, Large... | NGR-hTNF RITUXIMAB Doxorubicin Cyclophosphamid... Vincristine Prednisone | 18 Years - 80 Years | IRCCS San Raffaele | |
| [90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients | NCT06132737 | CNS Lymphoma | [90Y]Y-PentixaT... | 18 Years - 120 Years | Pentixapharm AG | |
| A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas | NCT04548648 | Central Nervous... | Acalabrutinib Isavuconazole | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors | NCT03220646 | Brain Tumor | abemaciclib abemaciclib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate | NCT01319591 | CNS Lymphoma CNS Involvement... | 18 Years - | Dana-Farber Cancer Institute | ||
| High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study | NCT01083342 | CNS Lymphoma | MTX, MVD, VIA | 20 Years - 70 Years | Samsung Medical Center | |
| RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor | NCT03536039 | Lymphoma, Large... | NGR-hTNF RITUXIMAB Doxorubicin Cyclophosphamid... Vincristine Prednisone | 18 Years - 80 Years | IRCCS San Raffaele | |
| Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma | NCT00596154 | CNS Lymphoma CNS Brain Cance... Non-Hodgkin's L... | Rituximab, Meth... | 18 Years - 72 Years | Memorial Sloan Kettering Cancer Center | |
| T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) | NCT06343311 | B-Cell Non-Hodg... Lymphoma, Non-H... Lymphomas Non-H... Non-Hodgkin Lym... Non-Hodgkin's L... Large B-Cell Ly... Lymphoma, Non-H... Lymphoma Refractory Non-... Relapsed Non-Ho... Lymphoma, Non-H... HIV Associated ... CNS Lymphoma High-grade B-ce... Refractory B-Ce... | EB103 | 18 Years - | Estrella Immunopharma, Inc. | |
| Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) | NCT00916630 | Central Nervous... | pemetrexed | 18 Years - | Massachusetts General Hospital | |
| Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma | NCT05351593 | CNS Lymphoma Primary Central... Secondary Centr... | Tafasitamab Lenalidomide | 18 Years - | University of California, San Francisco | |
| Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement | NCT05926427 | CNS Lymphoma | Orelabrutinib Rituximab Chemotherapy | 14 Years - 80 Years | Ruijin Hospital | |
| [68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients | NCT05222269 | CNS Lymphoma | 68Ga-PTF | 18 Years - 99 Years | Pentixapharm AG | |
| High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study | NCT01083342 | CNS Lymphoma | MTX, MVD, VIA | 20 Years - 70 Years | Samsung Medical Center | |
| A Phase I/II Study to Investigate the Use of VORAXAZE™ as Intended Intervention in Patients With CNSL | NCT04841434 | CNS Lymphoma | Voraxaze Inject... | 18 Years - | Charite University, Berlin, Germany | |
| Usefulness of Gadovist-enhanced FLAIR Imaging | NCT05293990 | Malignant Tumor... Brain Lymphoma CNS Lymphoma | Usefulness of G... | 19 Years - | Korea University Guro Hospital | |
| Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas | NCT01966809 | Brain Tumor, Re... | Photofrin photo... | 18 Years - | Medical College of Wisconsin | |
| High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma | NCT01182415 | Non-Hodgkin's L... CNS Lymphoma | Autologous stem... High-dose chemo... | 18 Years - 75 Years | Massachusetts General Hospital | |
| Usefulness of Gadovist-enhanced FLAIR Imaging | NCT05293990 | Malignant Tumor... Brain Lymphoma CNS Lymphoma | Usefulness of G... | 19 Years - | Korea University Guro Hospital | |
| Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma | NCT04656431 | Primary CNS Lym... | Hyperpolarized ... Magnetic resona... | 18 Years - | University of California, San Francisco | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma | NCT00221325 | Central Nervous... Intraocular Lym... | Intraventricula... | 18 Years - | University of California, San Francisco | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| [68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients | NCT05222269 | CNS Lymphoma | 68Ga-PTF | 18 Years - 99 Years | Pentixapharm AG | |
| CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study | NCT05828628 | CNS Lymphoma | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma | NCT00221325 | Central Nervous... Intraocular Lym... | Intraventricula... | 18 Years - | University of California, San Francisco |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
